Slowly Dendreon is improving on their margins. Below is the Cost of Rev-to-Revenue.
Q2 = 58%
Q3 = 85.5%
Q4 = 74%
Basically, they are improving on their fixed costs in relation to their new growth projections.
They did miss analyst ave revenue projection, but increased exposure and marketing is a work in progress.
Overall not bad, but they need to do better with the cost of revenues. (Inefficiencies is just an opportunity for improvement.)